results

Related by string. result * * EXECUTED THE RESULTS MAY . First Quarter Results . RECORD SIMULATED RESULTS DO . Third Quarter Results . Second Quarter Results . Financial Results . RESULTS HAVE CERTAIN INHERENT . RESULTING FROM THE INHERENT . ACTUAL RESULTS MIGHT DIFFER . actual results . Actual results . Operating Results . PERSONAL INJURY RESULTING DIRECTLY . Autopsy results *

Related by context. All words. (Click for frequent words.) 73 Results 55 re sults 55 resutls 53 findings 52 reults 51 resuts 50 earnings 49 SuperMedia specializes 49 outcome 49 outcomes 48 results.The 48 abysmal Shaiken 47 TABLE #.OS -#/# parent 47 theresults 47 quarterly 46 financialresults 46 Fund TSX AIF.UN 45 resultsof 45 ACCORD COPD 45 Cologuard 44 Significant assay 44 dang motors 44 NYSE PXP PXP 44 caustic fusion diamond 43 thefourth quarter 43 NYSE Amex ANV 43 fidaxomicin Phase 3 43 Unicorp Annual Report 43 Preliminary Results 43 thirdquarter 43 Pavelec regained consciousness 43 NASDAQ GPCB today 43 ENHANCE study 42 quaterly 42 Bracketed figures 42 microdiamond results 42 fullyear 42 commented Sean Durfy 42 NYSE ALJ Alon 42 Preliminary metallurgical 42 Sentiments soured 42 adding AJAX widgets 42 outturns 42 AVADO 42 Principled Technologies 42 EPS Excl 42 Co. Nasdaq DBLE 41 unblind 41 quarter 41 Negative Symptom Scale PANSS 41 Statutory Accounts 41 CLIRS 41 NYSE CHT Chunghwa 41 CAE FY# 41 Grouped Hockey 41 performance 41 Qtrly Avg 41 TEMSO 41 drilling wireline logs 41 expectations.The 41 IV RSD# 41 RAJAR figures 41 Mr. Eishen 41 unaudited consolidated balance sheets 41 Phase III ADT 41 Significant mineralized intercepts 41 F2Q 40 CEO Jussi Pesonen 40 negative UNII balances 40 Inc. NASDAQ ARQL 40 Board INTZ Intrusion 40 Homebuilder Lennar posts 40 secondquarter 40 CLIRS trial 40 profits 40 financialperformance 40 Dr. De Chirico 40 BRIM3 40 Sedar.com 40 NYSE Amex AZK 40 TSX VENTURE CMM 40 tabulations 40 Summarized below 40 APTIMA HPV assay 40 FQ4 40 NYSE VNR Vanguard 40 TSX VENTURE GOZ 40 SPIRIT FIRST 40 ITT ESI 40 Inc. Nasdaq LYTS 39 RSD# IV 39 Chuck Boehlke 39 Lauren Silvernail 39 Phase 2b RESTORE CLI 39 formal pharmacokinetic PK 39 GetGoal Phase III 39 NiMin Legacy 39 website www.steinwaymusical.com 39 BREVAGen ™ 39 intradialytic hypotension IDH 39 HORIZONS AMI trial 39 Tovaxin Phase IIb 39 fourthquarter 39 Company NASDAQ FEIC 39 unblinding 39 AGI Alamos 39 Nasdaq ALKS 39 andoperating 39 longitudinal cohort 39 invoiced shipment 39 NASDAQ CLDX 39 Chief Executive Aylwin Lewis 39 EnPro consolidated 39 NYSE IOC POMSoX 39 BioForce Nanosciences actual 39 restated financials 39 percutaneous cryoablation 39 Vocal Laboratories 39 auditors PricewaterhouseCoopers LLP 39 Quarterly Statistical Supplement 39 Clinical Diagnostics segment 39 EDEMA3 trial 39 Domilens 39 NYSE GRS Gammon 39 trastuzumab emtansine T DM1 39 preannounced 39 differ materiallyfrom those 39 NYSE Amex SOQ 39 F#Q# revenues 39 AVERROES 39 Caterer Compass 39 Inc. Nasdaq CPRX 39 Sensitivity analyzes 39 commented Kevin Hrusovsky 39 ENDEAVOR III 39 Post hoc 39 drug PTK ZK 39 figures 39 unaudited condensed 38 NASDAQ COHR 38 PRAGUE Komercni Banka 38 angiographic outcomes 38 preannouncement 38 IMPROVE HF 38 QTinno 38 Pharmacokinetic parameters 38 NASDAQ VMED LSE VMED 38 preclinical pharmacology 38 seat mile RASM 38 MARKET EXPECTATIONS 38 Findings 38 CRCT scores 38 backtests 38 bracelet charms sold 38 DCE MRI 38 German Purity Laws 38 Comparatives 38 IVS Associates 38 EDITDA 38 distort comparability 38 excludes nonrecurring items 38 MelaFind pivotal 38 reconciles GAAP 38 BOVESPA TAMM4 38 randomized Phase 2b 38 Prospective Plantings report 38 TSX VENTURE MEX 38 Oven frying 38 AMWO 38 Maine Timberlands 38 Summarized consolidated 38 Oncotype DX ® 38 Zacks Consensus Estimates 38 Earnings 38 PAL AMEX PAL.WS 38 Q3 38 http:/www.spec.org 38 TSX TCW 38 firstquarter 38 Maarten Bakker 38 negative preannouncements 38 Earnings Release Scheduled 38 Hovnanian trims 38 BoJ Tankan survey 38 betterthan expected 38 Meta analyzes 38 TSX IPL.UN 38 Solorel TM 38 bacteriological samples 38 Schedules 2Q 38 Repligen Corporation NASDAQ RGEN 38 Eltek commented 38 financialstatements 38 nonclinical studies 38 authenticity Yng 38 PCI ExTRACT TIMI 38 normalized FFO 38 numbers 38 nonGAAP 38 NYSE OSE RCL 38 molecular biomarker 38 spokeswoman Roberta Alenius 38 http:/news.yahoo.com/polls 38 Post mortem examination 38 Board TBIO 38 PreCISe 38 pro forma adjusted EBITDA 38 fidaxomicin Phase 38 CDEL commented 38 LSE YAU 38 Voter turnouts 38 Tocosol Paclitaxel 38 NYSE MIM MID 38 TC AMEX TCX 38 downhole radiometric logging 38 eTRAK 38 audited consolidated 38 Siebel Systems Annual Report 38 Chest x rays 38 condensed consolidated interim 37 Nasdaq MTOX 37 ELISpot 37 F1Q 37 PointRoll delivers 37 Broker Numis Securities 37 numerical specificity 37 my3KG 37 #Q filing 37 Norcraft Companies LP Norcraft 37 CFO Hal Mechler 37 RESULTS 37 MaryEllen Elia superintendent 37 NGNM 37 Pollster Tim Hibbitts 37 www.omnicomgroup.com InvestorRelations 37 budesonide MMX Phase III 37 Company TSX WXI 37 Literacy Test OSSLT 37 statistics 37 Bancorp Nasdaq TBBK 37 PROLARIS 37 CUSTOM III 37 illumigene 37 Macy KB Toys 37 Preliminary Assessment Study 37 RC2 NASDAQ RCRC 37 Inc. NASDAQ BLUD 37 pro forma 37 PreGen Plus 37 robust F#Q# 37 pivotal bioequivalence 37 TSX VENTURE CFZ 37 Scintillometer Readings 37 PRIMO CABG2 37 NYSE Amex TGB Taseko 37 Q1 37 TASE CAMT 37 upon Trevali metallurgical 37 preclinical pharmacokinetic 37 NLX P# 37 Phase 2b monotherapy 37 margins 37 TSX VENTURE OGR 37 NAEP scores 37 arlen specter election 37 bronchial lavage 37 Reiterates Guidance 37 RAD SVT 37 Paul Averback 37 Q4 37 Result 37 www.spec.org 37 interim condensed consolidated 37 metrics 37 Dr. Baim 37 Discovery Labs KL4 37 www.omtr.com 37 FQ = fiscal 37 Q2 37 SEMAFO TSX SMF 37 virological response 37 Inc. NASDAQ HEPH 37 PROGENSA PCA3 assay 37 Russ Knittel 37 earnigns 37 NASDAQ GEOI 37 MEMPHIS Tenn. AutoZone 37 CEO Philip Verges 37 phase IIb study 37 geochemical assay 37 Company website www.gcgaming.com 37 NewHeights Software Corporation 37 Albert W. Ondis 37 netincome 37 Accountability Office EQAO 37 SEDAR EDGAR 37 http:/www.omtr.com 37 FIRST NORTH PXXS 37 Oncotype Dx 37 Corp. NASDAQ JJSF 37 TASE CAMT announced 37 toxicologies 37 Flamel Technologies NASDAQ FLML 37 Inc. NASDAQ COHU 37 rebased OCF growth 37 Ofer Segev executive 37 eTag assays 37 Inc. NASDAQ SNUS 37 BETAS 37 holes #WR# 37 sequential improvement 37 TSX VENTURE ZED 37 adversely affect NetEase 37 BHIVA 37 pretax profits 37 IGM TSX IGM 37 Feasibility Study FS 37 http:/www.smics.com 37 Cervista 37 discussed NuroPro Power3 37 Inc. NYSE LUB 37 operable node 37 ANALYST TAKE Analysts 37 pages SERP 37 Genta Incorporated OTCBB 37 KRAS status 37 datapoints 37 TLR Timberline 37 posttest 37 % 2bcars 37 initiate Phase 2a 37 cannabinor 37 TGA TransGlobe 36 SigmaTron 36 adopting SFAS #R 36 BC SeraPro 36 attached unaudited condensed 36 website www.highlandfunds.com 36 adjusted EPS 36 analystsâ 36 TSX VENTURE SDX 36 Results Exceed Expectations 36 EPS accretion 36 SEQureDx 36 Patrick Spratt KVH 36 TASE ITRN 36 Phase 2b randomized 36 MFFO 36 profit 36 condensed consolidated balance sheets 36 clinical meaningfulness 36 DMIST 36 Ampac ISP Corp. 36 IIa clinical trial 36 quarter# 36 QSBO 36 FFO Declines 36 NASDAQ APPA specialty 36 Oncotype DX Recurrence Score 36 Michael Deikmann 36 AIM EGU TSX EGU 36 heap leach amenability 36 pulp metallic 36 gains 36 TSX VENTURE SHC 36 ARMONK NY MBIA 36 ruxolitinib 36 Nasdaq ONXX today 36 orthopedist Dr. Andrew Cosgarea 36 SUCCEED trial 36 Company NYSE DRH 36 PillCam Colon 36 Company TSX ANV 36 TSX LMA hereinafter 36 seasonally slowest 36 RIO Lipids 36 TSMC #nm iPDK 36 comparatives 36 FQ2 36 OVA1 ® 36 Inc. NASDAQ MWIV 36 Inc. Nasdaq CRZO 36 Inc. NASDAQ NXST 36 SCHEDULED TO PREMIERE 36 AMEX ABL 36 truncated Golden Globes 36 SPECjbb# benchmark 36 futureresults 36 meta regression 36 TTF Therapy 36 intravascular ultrasonography 36 Nasdaq GS BRNC 36 Zacks Estimate 36 normalized EPS 36 Format Discussion 36 Inc. NASDAQ ADPI 36 Kerala SSLC 36 CAT IIM 36 Carolinas PEC 36 Nasdaq CYBE today 36 data 36 TSX BNK AIM BNK 36 NYSE CJR 36 CAPT scores 36 ORAL Sync 36 endoscopic gastric ulcers 36 pacings 36 Company NASDAQ IMOS 36 Inc. NASDAQ CRZO 36 Inc. NASDAQ PEDH 36 NASDAQ SLXP today 36 Inc. Nasdaq ZGEN 36 Corporation NASDAQ THFF 36 OCF margin 36 tallies 36 Nasdaq VRTX 36 Cervista HPV HR 36 thanexpected 36 RISE FALL NEUTRAL 36 methodologically sound 36 TSX VENTURE SBB 36 viral kinetic 36 midquarter 36 IMPACT DCM 36 EquiTrend ® 36 Wireline logs 36 Incidental findings 36 Geneva broker Helvea 36 NYSE Euronext PHARM 36 VaxGen AIDSVAX 36 methylation biomarkers 36 TRY.B 36 MARKET EXPECTATIONS Analysts 36 Non GAAP reconciliations 36 www.liquidityservicesinc.com 36 http:/surveys.ap.org 36 NYSE AMEX LCI 36 un audited 36 rALLy trial 36 Inc. Nasdaq RCKY 36 TOFUTTI Announces 36 TSX NI www.victorynickel.ca 36 Quarter Results 36 pro gress 36 F4Q 36 earnings preannouncements 36 Dick Alario Chairman 36 un audited consolidated 36 USD#.#m USD#.# per [002] 36 AGRASTIM ® 36 F#H# 36 http:/investor.manpower.com 36 anaylsis 36 RESTORE CLI 36 todiffer materially 36 TSX VENTURE AUN 36 Zybrestat 36 teriflunomide 36 TSX ORE 36 bank OTCBB LTLB 36 www.radvision.com 36 Brunswick Timberlands 36 animal xenograft models 36 www.cbseresults.nic.in 36 fi ndings 36 gamma logs 36 projections 36 Trust TSX CWT.UN 36 EAU Eldorado 36 statements 36 PGxHealth FAMILION 36 Board BHWX 36 riociguat 35 responses 35 abstracts summarizing 35 Inc. NASDAQ MLNK 35 accompanying condensed consolidated 35 Nasdaq NYMX 35 MacroChem actual 35 pelvic ultrasound 35 MEAP scores 35 outlook 35 ABSORB trial 35 spokesman Terry Alberstein 35 creel checks 35 PLCO trial 35 leach recoveries 35 Outpatient Setting 35 cash flows 35 OTCBB NSFDF FRANKFURT EFW 35 CPAP adherence 35 tables summarize 35 Tesmilifene 35 non gaap 35 diluted EPS 35 Inc. Nasdaq ALXA 35 HC2 test 35 Inc. NASDAQ EXEL 35 trastuzumab DM1 T DM1 35 these Tumorgrafts closely 35 topical INCB# 35 MEND CABG 35 enoximone 35 incorrect actual 35 tests 35 REVIVE TA 35 IPA SBRB 35 NASDAQ PAAS Pan 35 Linda Wilmesherr 35 AMR CORPORATION CONSOLIDATED 35 pure fructose 35 accompanying unaudited consolidated 35 Randomized clinical trials 35 unacceptable Chairman Lanty 35 website www.minera irl.com 35 TSX VENTURE GSH 35 Inc. NASDAQ LTRE 35 HCV RESPOND 2 35 NSABP C 35 TSX PBG 35 www.essexpropertytrust.com 35 BUSINESS OUTLOOK 35 zotarolimus 35 Inc. Nasdaq GHDX 35 Casa Berardi mine 35 Average Yearly Progress 35 CaPre TM 35 Lanty Smith Wachovia 35 value www.bluefly.com 35 Nasdaq MAPP 35 Q4 LY 35 conclusions 35 R Nasdaq NTII 35 report 35 F4Q EPS 35 website www.mbandt.com 35 Earnings Preview KB Home 35 NYSE Amex AIS 35 NYSE ETY 35 semi variograms 35 NASDAQ GS TRAD 35 heps 35 Business Opinion QSBO 35 SS NOI 35 oulook 35 guidance 35 result 35 NADiA ProsVue 35 Precautionary X rays 35 2Q FY# [002] 35 barometers flashed 35 aconference call 35 specified secondary endpoints 35 sonographic findings 35 OvaRex 35 ISTEP Plus scores 35 web site http:/www.nasd-law.com/documents/classvrIcy Cape 35 SYMMETRY trial 35 Nyngan Scandium Project 35 Frankfurt TecDAX SOW 35 www.isecuretrac.com 35 renamed #mattress.com 35 Oncotype DX breast cancer 35 www.results.nic.in 35 CEO Jai Nagarkatti 35 http:/www.sap.com/investor 35 SKVY 35 website www.fblfinancial.com 35 ToGA 35 Payout ratios 35 preliminary metallurgical testwork 35 PubMatic AdPrice Index 35 Farmstead Telephone 35 Inaccurate portrayals 35 EPS 35 thequarter 35 Kumar Anshumali 35 GRAVITAS trial 35 TSX VENTURE DIB 35 B. Lynne Parshall 35 Sean Roosen President 35 SRK Consulting SRK 35 alvespimycin 35 Cluuz search 35 NYSE COG 35 Company website http:/www.orl.co.il 35 methylation markers 35 Inc. Nasdaq VASC 35 Inc. Nasdaq ACOR 35 Ghazni Paktika 35 NanoKnife IRE System 35 QTinno TM 35 sNDA submission 35 Earnings Preview Activision Blizzard 35 Deikmann 35 growthin 35 Western blot 35 LUMINEERS BY CERINATE 35 outlooks 35 Evaporative Cooling segment 35 Amtech commented 35 comparables 35 narrows Quick Facts 35 DAC unlocking 35 SEC Regulation FD 35 Fauci confessed 35 Corporation Nasdaq NVEC 35 AVGCF Avion 35 SS NOI helps 35 Power3 Alzheimer disease 35 radiographic outcomes 35 TSX PDL.WT AMEX 35 PDRT 35 PC DAC Exendin 35 Regression analyzes 35 Inc GHDX 35 spokesman Fritz Schmuhl 35 Q4 FY# [001] 35 Biophan anticipates 35 NASDAQ MERX 35 Nigel Pendse author 35 Q2 F# 35 unaudited unconsolidated 35 LungExpress Dx TM 35 confirmatory 35 Inc. Nasdaq VRML 35 visit www.iaaf.org 35 Inc. Nasdaq MDVN 35 Annualizing 35 efficiency ratio teb 35 newsflow 35 Nasdaq NFLD announced 35 Simulations Plus Reports 35 Inc. Nasdaq MSSR 35 reaudit 35 suggest Roche Invirase 35 BIOTECH STOCKS Drug 35 bepotastine besilate nasal spray 35 expectations 35 evaluating mipomersen 35 interims 35 TSX VENTURE ABM 35 Nasdaq GPCB 35 Dengue Hemorrhagic Virus 35 LE SN# 35 QTinno ™ 35 APTIMA HPV 35 AIM CMCL 35 Inc. OTC CDCO 35 www.ClinicalTrials.gov 35 Corporation Amex RIV 35 Inc. NASDAQ MIPI 35 PROactive study 35 Negatively impacting 35 plecanatide 35 Education Next PEPG 35 AIM BNK 35 beats f'casts 35 Core Hand Held 35 TSX OZN AMEX OZN 35 NYSE Amex GSX 35 MERIT ES 35 analyst Sjoerd Ummels 35 Q4 F# 35 NASDAQ TWIN 35 PRIMO CABG 35 Kalsaka mine 35 RUSKIN Fla. Authorities 35 www.lifepointhospitals.com 35 TSX ARZ AMEX AZK 35 elacytarabine 35 PEARL HF 35 Q4 CY# 35 NASDAQ MFRI 35 GALNS 35 Inc. Nasdaq TELK 35 TSX VENTURE BLG 35 Ltd. NASDAQ GIII 35 Genz # 35 transient elastography 35 DanceCenter segment parody 35 serologic tests 35 GVAX AML 35 leachability 35 PROFIT JUMPS 35 retabulation 35 generation URAT1 inhibitor 35 quarterly Tankan 35 NYSE THI 35 initiate Phase 2b 35 TSX LUN OMX LUMI 35 Quarter Fiscal 35 NYSE Amex NXG 35 AVN# Phase 35 Karnataka SSLC 35 Cogdell Spencer Earnings 35 test 35 TSX VENTURE EXN 35 Multivariable logistic regression 35 Miriam Vos 35 mom Leni Calas 35 OECD PISA 35 colleague Sana Inoue 35 Q1 FY# [001] 35 TSX VENTURE GRR 35 Third Quarter Results 35 inconclusive 35 pharmacokinetic characteristics 35 Inc. Nasdaq MAXY 35 preliminary 35 iLEAP 35 TOLAMBA 34 preclinical efficacy 34 varespladib 34 VESTASYNC 34 hole DDH# 34 NYSE Amex MFN 34 SEK#.#bn [002] 34 Adtegrity.com Reports 34 www.mapleleaf.com 34 Carol Meyrowitz TJX 34 http:/www.ap-gfkpoll.com 34 differ materially fromthose 34 performance orachievements 34 flotation testwork 34 iroxanadine 34 #:# AM Central/# 34 www.genelogic.com 34 items affecting comparability 34 Wytowno # 1 34 CEO Rejean Robitaille 34 JNTU Anantapur 34 Nasdaq UTHR 34 Albany Molecular AMRI 34 dry dockings 34 audited financials 34 R# #mg BID 34 anti JCV antibody 34 www.torchmarkcorp.com 34 Wrestling Wrap Up 34 VTEM airborne surveys 34 Highlights Achieved 34 Inc. NASDAQ MIGP 34 Cascade Microtech NASDAQ CSCD 34 TSX DNG 34 Relevant Triad Guaranty 34 TSX PMZ.UN 34 pharmacodynamic effects 34 TSX BKP 34 EMPOWER TM 34 S. maltophilia 34 ALSYMPCA 34 maydiffer materially 34 Corp. NASDAQ ARKR 34 PARTNER Trial 34 http:/www.keryx.com 34 NYSE GIL 34 CHMP opinion 34 TSX ELD AMEX EGO 34 Inc. NASDAQ NBIX 34 ChemoFx 34 IGXT IntelGenx today 34 Inc. NASDAQ VLCM 34 www.ahtreit.com 34 Inc. Nasdaq OPTR 34 DNAWitness Y 34 Nasdaq SGMO announced 34 accretion dilution 34 Clinicaltrials.gov 34 Inc. Nasdaq CVCO 34 pro forma financials 34 http:/www.nyseeuronext.com/ir 34 double digit growths 34 transrectal ultrasound 34 demographic subgroups 34 NASDAQ DMAN 34 VaR calculations 34 Mechanistic studies 34 Inc. NASDAQ CBRX 34 NYSE IAG BOTSWANA 34 Inc. Nasdaq SIGI 34 Quarter Fiscal Year 34 Exact totals 34 Inc. NASDAQ TRMP 34 ACUITY trial 34 CLARITY study 34 PowerPoint presentation highlighting 34 Nasdaq PCYC 34 outrageous Auletta 34 boldface disclaimer 34 EquiTrend 34 Flow cytometry 34 Eaglehead Property 34 Pearson correlation coefficients 34 www.apollogold.com 34 NYSE HWD 34 http:/investor.google.com/webcast.html 34 Spokeswoman Jennifer Weyrauch 34 TGP Frankfurt 34 genomewide association studies 34 Inc. Nasdaq BIOD 34 Hedgehog antagonist 34 CBI distributive 34 ENHANCE trial 34 journal Resuscitation 34 BHEM surveys 34 Earnings Preview EBay 34 Craig Newschaffer 34 CT perfusion 34 Statistical Supplement 34 http:/investor.verisign.com 34 www.cdw.com investor 34 regression equations 34 Inc. NASDAQ SAFT 34 Inc. EET.TSX 34 REBIT 34 marginally accretive 34 Resverlogix Corp. Resverlogix 34 Michael Klayko Brocade 34 Detect Ready MRSA 34 preclinically 34 PITX2 methylation 34 commercially exploitable mineralization 34 NASDAQ ARRY 34 TSX PLS 34 website www.harrisinteractive.com ir 34 Japan tankan 34 Wyeth WYE.N 行情 34 CardioBip 34 ACSI methodology 34 perinatal outcomes 34 factorsthat 34 2nd Quarter Results 34 SoFIE 34 interim unaudited consolidated 34 SIX Estimates 34 mSEPT9 34 Hubbell Incorporated NYSE HUBA 34 SVR# 34 Alzhemed 34 invoiced shipments 34 acronym INA 34 NASDAQ CRFT 34 blood serum biomarkers 34 Mazin Shuaib 34 missed analystsā 34 forecasts 34 Traumatic asphyxiation 34 ISTEP + scores 34 recoveries 34 Corp. TSX LSG 34 GuideLiner catheter 34 theoverall 34 TSX BLU 34 Bio Analytical Measurement 34 www.Limitedbrands.com 34 International Nasdaq PRAI 34 TSX Venture BCM 34 AGM.A 34 Nasdaq NPSP announced 34 scores 34 VersaFilm 34 AMEX DDD 34 Financial Results 34 unaudited 34 Non GAAP Consolidated Statements 34 ENDEAVOR clinical 34 TSX COM 34 NASDAQ VRGY premier 34 HERmark assay 34 extreme fractiousness 34 believes EBDDT 34 AZCAR Announces 34 brivaracetam 34 DSD Dairy segment 34 seagate.com 34 ILLUMINATE 34 Phase 1a clinical 34 cabozantinib 34 operating EBIDA 34 EPL EPL 34 financials 34 NYSE Amex TIS 34 Swiss KOF leading 34 JS Whang Chief Executive 34 microdiamonds 34 Inc. Nasdaq CRDN 34 Timeshare segment 34 Newspaper Audience Databank 34 VIENNA Austria Erste 34 Patrick J. Balthrop 34 Inc. Nasdaq BRKS 34 Inc. Nasdaq EXEL 34 cblproperties.com 34 endedSeptember 34 TELECOM STOCKS Telecoms 34 Class XII CBSE 34 F#Q# EPS ahead 34 SIMPADICO trial 34 Company Nasdaq IMOS 34 Merchant Confidence Index 34 Preliminary Assessment PA 34 Rajar figures 34 website www.rainyriverresources.com 34 Marco Strittmatter 34 Inc. NASDAQ ALTH 34 confirmatory clinical 34 looking statementsaEUR describe 34 Thorough QT 34 ACCORD Lipid 34 Pervasip actual 34 ClosureFAST catheter 34 www.chesapeakelodgingtrust.com 34 audited 34 Energy Efficiency Indicator 34 efficacy endpoint 34 F1Q EPS 34 unaudited consolidated interim 34 LTRE 34 NYSE KFS 34 TASKi2 34 SPIRIT IV 34 initiate Phase IIb 34 NMP# 34 Cash Dividend Declared 34 prenatal Down syndrome 34 Supplemental Schedules 34 verdict 34 Ligand judgment 34 continuingoperations 34 statements arebased 34 journal Ophthalmology 34 Northwater Market Neutral 34 conclusive 34 Inc. NASDAQ ULTA 34 ostarine 34 closet Teerapop 34 EARNINGS OUTLOOK 34 NASDAQ BMTI 34 progress 34 Inc. Nasdaq CNSL 34 exclude nonrecurring items 34 UroVysion 34 DNAWitness Mito 34 NASDAQ HYTM 34 Nasdaq THRX 34 FM LSE FQM 34 Inc. Nasdaq ZIPR 34 Bechara findings 34 endlessly dissected term 34 nonrandomized studies 34 unaudited Consolidated Statement 34 aq q 34 adversely affect Linktone 34 NITON 34 Multivariate analysis 34 expenses totaled Ps 34 www.Bunge.com 34 HORSHAM Pa. Toll Brothers 34 Items impacting comparability 34 EGS# 34 VerifyNow P#Y# Test 34 TSX GGC 34 Inc. NASDAQ ACOR 34 ABCSG 34 EBDDT 34 AMEX GRS 34 Inc. NASDAQ NTMD 34 iniparib 34 ejaculatory function 34 DNA methylation markers 34 Zvi Slonimsky CEO 34 Earnings Release Attachments 34 BLOOM Behavioral modification 34 methodological flaws 34 AIPGMEE 34 OTCBB RDIAF announces 34 ACLU Cecillia Wang 34 #.# perdiluted 34 OSLO QEC 34 Ultimate Squeegee 34 Fabricated Products segment 34 Including discontinued operations 34 Alan Vituli Chairman 34 AM Eastern Daylight 34 Inc. NASDAQ MGAM 34 Q2 FY# [001] 34 phase IIa 34 Supplemental Financials 34 #QF# 34 #QSB 34 Corporation NASDAQ DENN 34 Nasdaq CRDC 34 www.lscc.com 34 acquired Brooks Eckerd 34 PINPOINT SPY scope 34 cutover readiness 34 Multiple logistic regression 34 SSNOI

Back to home page